7 reports

  • EUROPE ONCOLOGY TESTING MARKET REVENUE, BY APPLICATION AND CANCER CARE (2017) ($MN)
  • LIQUID BIOPSY GLOBAL MARKET REVENUE, BY APPLICATION, (2017 VS 2024) ($MN)

AND ONLY ONE LABORATORY.

  • Oncology
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

NON-SYNTHETIC TISSUE SEALANTS BASED ON THEIR COMPOSITION CAN BE CLASSIFIED AS FIBRIN-BASED TISSUE SEALANTS, AND OTHER PROTEIN-BASED TISSUE SEALANTS.

  • Oncology
  • Southern Europe
  • Spain
  • Market Size
  • Grifols, S.A.

NON-SYNTHETIC TISSUE SEALANTS BASED ON THEIR COMPOSITION CAN BE CLASSIFIED AS FIBRIN-BASED TISSUE SEALANTS, AND OTHER PROTEIN-BASED TISSUE SEALANTS.

  • Oncology
  • China
  • East Asia
  • Market Segment
  • Market Size

THE COMMERCIAL LAUNCH OF THE FIBRIN SEALANT REMAINS PLANNED BY MID-2011.

  • Oncology
  • Canada
  • North America
  • Forecast
  • Market Size

LAUNCHED ENHANCEMENTS AND UPGRADES FOR A RANGE OF BAXTER PRODUCTS TO PROMOTE SAFETY AND INCREASE EASE OF USE, INCLUDING THE AK ## HEMODIALYSIS SYSTEM, FLOSEAL HEMOSTATIC MATRIX, TISSEEL [FIBRIN SEALANT] AND THE SIGMA SPECTRUM INFUSION SYSTEM.

  • Anesthesia Equipment
  • Medical Device
  • Oncology
  • Respiratory Device
  • Market Size

NON-SYNTHETIC TISSUE SEALANTS BASED ON THEIR COMPOSITION CAN BE CLASSIFIED AS FIBRIN-BASED TISSUE SEALANTS, AND OTHER PROTEIN-BASED TISSUE SEALANTS.

  • Oncology
  • Southern Europe
  • Spain
  • Forecast
  • Market Size

You can easily book an appointment with one online.

  • Oncology
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Ethicon, Inc.
  • Medtronic, Inc.